SHORT-TERM DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING IN PATIENTS WITH ACUTE CORONARY SYNDROMES: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Nascimento, Bruno Ramos
Gewehr, Douglas M.
Soares Pinho De Carvalho, Lara Melo
Silveira, Giullia
Rivera, Andre
Lopes, Renato D.
De Paula Carvalho, Pedro Emanuel
机构：
[1] Hosp Madre Teresa, Serv Hemodinam, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1053-03
引用
收藏
页码：846 / 846
页数：1
相关论文
共 50 条
  • [1] Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes
    Carvalho, Pedro E. P.
    Gewehr, Douglas M.
    Nascimento, Bruno R.
    Melo, Lara
    Burkhardt, Giullia
    Rivera, Andre
    Braga, Marcelo A. P.
    Guimaraes, Patricia O.
    Mehran, Roxana
    Windecker, Stephan
    Valgimigli, Marco
    Angiolillo, Dominick J.
    Bhatt, Deepak L.
    Sandoval, Yader
    Chen, Shao-Liang
    Stone, Gregg W.
    Lopes, Renato D.
    JAMA CARDIOLOGY, 2024, 9 (12) : 1094 - 1105
  • [2] Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials
    Cassese, Salvatore
    Byrne, Robert A.
    Ndrepepa, Gjin
    Schunkert, Heribert
    Fusaro, Massimiliano
    Kastrati, Adnan
    CLINICAL RESEARCH IN CARDIOLOGY, 2015, 104 (10) : 887 - 901
  • [3] Prolonged dual antiplatelet therapy after drug-eluting stenting: meta-analysis of randomized trials
    Salvatore Cassese
    Robert A. Byrne
    Gjin Ndrepepa
    Heribert Schunkert
    Massimiliano Fusaro
    Adnan Kastrati
    Clinical Research in Cardiology, 2015, 104 : 887 - 901
  • [4] SHORT-TERM VERSUS LONG-TERM DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Silveira, Giullia
    De Paula Carvalho, Pedro Emanuel
    Macedo, Harthur Moreira
    Goncalves, Livian De Sousa
    Seixas Rangel Maciel, Anna Carolina Fontoura
    Gomes, Wilton Francisco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1222 - 1222
  • [5] Efficacy and safety of short-term (≤ 6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials
    Xiang, Chun-Lin
    Gong, Yi-Zhen
    Zeng, Long-Jia
    Luo, Bei-Bei
    Xu, Jian
    He, Yan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 17 (03): : 168 - 175
  • [6] Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
    Luo, Lin
    Wang, Shenglin
    Tang, Kai
    Yang, Xu
    Wu, Jianli
    Wang, Dan
    Xu, Liqiong
    Feng, Tao
    Li, Dejin
    Ran, Jiuju
    Li, Debo
    Zhang, Li
    Zhao, Dan
    MEDICINE, 2022, 101 (42) : E31158
  • [7] Benefits and risks of long-term duration of dual antiplatelet therapy after drug-eluting stenting: A meta-analysis of randomized trials
    Valgimigli, Marco
    Park, Seung-Jung
    Kim, Hyo-Soo
    Park, Kyung Woo
    Park, Duk-Woo
    Tricoci, Pierluigi
    Ferrante, Giuseppe
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (03) : 2579 - 2587
  • [8] BENEFITS AND RISKS OF LONG-TERM DURATION OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING: A META-ANALYSIS OF RANDOMIZED TRIALS
    Ferrante, G.
    Park, S. J.
    Kim, H. S.
    Park, K. W.
    Park, D. W.
    Valgimigli, M.
    CARDIOLOGY, 2013, 125 : 425 - 425
  • [9] Best Duration of Dual Antiplatelet Therapy after Drug-Eluting Stent implantation: A Network Meta-analysis of Randomized Controlled Trials
    Barbarawi, Mahmoud
    Kheiri, Babikir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B326 - B326
  • [10] Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation in East Asians: A Network Meta-Analysis of Randomized Controlled Trials
    Zhong, Peng-Yu
    Shang, Yao-Sheng
    Bai, Nan
    Ma, Ying
    Niu, Ying
    Wang, Zhi-Lu
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (02) : 216 - 225
12345